Advanced search
Publication Cover
mAbs Volume 5, 2013 - Issue 3
Submit an article Journal homepage
1,480
Views
18
CrossRef citations to date
0
Altmetric
Report

Agonistic TAM-163 antibody targeting tyrosine kinase receptor-B

Applying mechanistic modeling to enable preclinical to clinical translation and guide clinical trial design

Yulia Vugmeyster Pharmacokinetics, Dynamics and Metabolism; Pfizer, Inc.; Cambridge, MA USA
,
Cynthia Rohde Drug Safety R&D; Pfizer, Inc.; Cambridge, MA USA
,
Mylene Perreault Cardiovascular and Metabolic Diseases Research Unit; Pfizer, Inc.; Cambridge, MA USA
,
Ruth E. Gimeno Chief Scientific Officer; Eli Lilly & Co; Indianapolis, IN USA
&
Pratap Singh Pharmacokinetics, Dynamics and Metabolism; Pfizer, Inc.; Cambridge, MA USACorrespondence[email protected]
Pages 373-383 | Received 19 Oct 2012, Accepted 29 Jan 2013, Published online: 25 Mar 2013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.